课题基金 / 基金详情

INTERACTIONS OF LP(A) WITH VASCULAR EXTRACELLULAR MATRIX

INTERACTIONS OF LP(A) WITH VASCULAR EXTRACELLULAR MATRIX
LP(A) 与血管细胞外基质的相互作用
批准号:
2885178
负责人:
Angelo M Scanu
金额:
$27.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-16 至 2003-06-30

项目摘要

项目成果

Angelo M Scanu的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):脂蛋白(a), Lp(a),是一种
英文摘要
DESCRIPTION (adapted from applicant's abstract): Lipoprotein(a), Lp(a), is a low density lipoprotein (LDL) having as a protein moiety apoB100 linked by a single disulfide bridge to apolipoprotein(a), apo(a), a multikringle structure with a close homology to plasminogen. Lp(a) has been associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD). Vascular retention of Lp(a) via interactions with macromolecules of the extracellular matrix (ECM) of the arterial wall has been among the suggested mechanisms. Since in the atherosclerotic vessel Lp(a) is preferentially retained over LDL, a particle which only contains apoB100, this difference in retention is likely related to the presence of apo(a) in Lp(a). Our studies are designed to test the hypothesis. To this effect, we wish to define the molecular phenotype as well as derivatives thereof obtained by the action of elastases and metalloproteinases (MMPs) which cleave Lp(a)/apo(a). Complementary information will be obtained by using natural mutants of Lp(a) and products generated by recombinant techniques. In terms of proteoglycans (PG), we will continue our studies on decorin which we have already shown to bind to Lp(a) by both electrostatic (apoB100-glycosaminoglycan (GAG)) and hydrophobic interactions (apo(a)-decorin core protein) and extend these studies to the protein core of the other two main PG of the arterial intima, biglycan and versican. All of these PGs will be obtained by both recombinant technology and extraction from arterial tissues from cadavers. We will continue our studies on the binding of Lp(a) and derivatives to fibrinogen also with the goal of defining the molecular basis for the superbinding capacity for fibrinogen of Lp(a) species identified in the plasma of subjects at a high risk for atherosclerotic cardiovascular disease. Moreover the potential cardiovascular pathogenicity of the complexes formed from the in vitro interaction between Lp(a)/apo(a) and matrix macromolecules, will be examined for their susceptibility to the action of proteolytic enzymes with an emphasis on MMPs shown to independently cleave Lp(a)/apo(a) and matrix macromolecules. We will also determine the capacity of these complexes to interact with cultured human macrophages and their potential to stimulate these cells to synthesize and secrete MMPs capable of modifying Lp(a)/apo(a), PGs and derivatives thereof. Underlying these studies is the hypothesis, that the MMP-mediated changes in Lp(a)/apo(a) are favored by the inflammatory milieu of the human atheroma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLOGY OF PROTEOLYTIC DERIVATIVE OF LP(A)
Biology of Proteolytic Derivatives of Lp(a)
  • 批准号:
    7577397
  • 项目类别:
  • 资助金额:
    $36.74万
  • 财政年份:
    2001
  • 负责人:
    Angelo M Scanu
  • 依托单位:
Biology of Proteolytic Derivatives of Lp(a)
  • 批准号:
    6865008
  • 项目类别:
  • 资助金额:
    $38.75万
  • 财政年份:
    2001
  • 负责人:
    Angelo M Scanu
  • 依托单位:
BIOLOGY OF PROTEOLYTIC DERIVATIVES OF LP(A)
  • 批准号:
    6530719
  • 项目类别:
  • 资助金额:
    $33.92万
  • 财政年份:
    2001
  • 负责人:
    Angelo M Scanu
  • 依托单位:
海外基金